Epigenetic Sensitisation of Chemotherapeutic Compounds in Non- Small Cell Lung Cancer

Ghaliah Obaid F Alnefaie
Lung cancer is currently the highest cancer-related cause of death worldwide, accounting for 1.7 million deaths in 2018. Non-small cell carcinoma (NSCLC) is the most frequent type, accounting for approximately 80% of all lung cancer cases. Chemotherapy is still the first-line therapy offered to NSCLC patients in most countries. While new therapies (targeted compounds, immunotherapy) are evolving, chemotherapy is considered to be used for at least two more decades. Resistance to chemotherapy is among the...
This data repository is not currently reporting usage information. For information on how your repository can submit usage information, please see our documentation.